Inventor
Johan D. Oslob
Inventor
Sunnyvale, CA, US
Overview
Patents· 36 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds26%
A61KPreparations for medical, dental or toiletry purposes21%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations21%
C07CAcyclic or carbocyclic compounds12%
C04BLime, magnesia7%
A61BDiagnosis4%
G01NInvestigating or analysing materials by determining their chemical or physical properties4%
Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests2%
C07BGeneral methods of organic chemistry1%
C07KPeptides1%
PatentTitleYear
11,123,3374-methylsulfonyl-substituted piperidine urea compounds202111,034,693Substituted 5,6,7,8-tetrahydropyrido[2,3-d]pyrimidine-2,4-diones for treating cardiac diseases202110,758,5254-methylsulfonyl-substituted piperidine urea compounds202010,226,449Heterocyclic modulators of lipid synthesis and combinations thereof201910,189,822Heterocyclic modulators of lipid synthesis201910,124,000Modulators of cellular adhesion201810,118,913Heterocyclic modulators of lipid synthesis201810,053,450Heterocyclic modulators of lipid synthesis20189,925,177'4-methylsulfonyl-substituted piperidine urea compounds'20189,809,591'Heterocyclic modulators of lipid synthesis'20179,663,516'Bicyclic-pyrimidinedione compounds'20179,624,173'Heterocyclic modulators of lipid synthesis'20179,585,883'Pyrimidinedione compounds'20179,428,502'Heterocyclic modulators of lipid synthesis'20169,248,126'Modulators of cellular adhesion'20169,216,174'Modulators of cellular adhesion'20159,199,945'Cycloalkyl-substituted pyrimidinedione compounds'20159,181,200'Pyrimidinedione compounds'20159,051,297'Compositions and methods for treatment'20159,045,458'Compositions and methods for treatment'20159,045,457'Compositions and methods for treatment'20158,871,790'Heterocyclic modulators of lipid synthesis'20148,771,715'Compositions and methods for treatment'20148,758,776'Compositions and methods for treatment'20148,084,047'Compositions and methods for treatment of eye disorders'20118,071,617'Modulators of cellular adhesion'20117,989,626'Modulators of cellular adhesion'20117,932,257'Substituted pyrazolo[4,3-d]pyrimidines as aurora kinase inhibitors'20117,928,122'Modulators of cellular adhesion'20117,790,743'Modulators of cellular adhesion'20107,767,687'Pyrido pyrimidinones, dihydro pyrimido pyrimidinones and pteridinones useful as RAF kinase inhibitors'20107,745,460'Modulators of cellular adhesion'20107,601,725'Thienopyrimidines useful as Aurora kinase inhibitors'20097,314,938'Modulators of cellular adhesion'20087,115,654'Caspase-1 inhibitors and methods for their use'20066,806,279'Small-molecule inhibitors of interleukin-2'2004Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2004–2011Patents assigned to SUNESIS PHARMACEUTICALS INC (6)· patent assignee history
2004–2021Based in Sunnyvale, CA, US· patent location history
2011–2018Patents assigned to SARCODE BIOSCIENCE INC (10)· patent assignee history
2011–2014Patents assigned to BARR KENNETH (4)· patent assignee history
2014–2019Patents assigned to 3 V BIOSCIENCES INC (5)· patent assignee history
2015–2021Patents assigned to MYOKARDIA INC (8)· patent assignee history
2019Based in Menlo Park, CA, US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| SARCODE BIOSCIENCE INC | 10 | 2011–2018 |
| MYOKARDIA INC | 8 | 2015–2021 |
| SUNESIS PHARMACEUTICALS INC | 6 | 2004–2011 |
| 3 V BIOSCIENCES INC | 5 | 2014–2019 |
| BARR KENNETH | 4 | 2011–2014 |
Locations
| Location | Patents | Span |
|---|---|---|
| Sunnyvale, California, US | 34 | 2004–2021 |
| Menlo Park, California, US | 2 | 2019 |